These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3312022)

  • 1. Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.
    Bauernfeind A; Hörl G
    Infection; 1987; 15(4):257-9. PubMed ID: 3312022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    J Antimicrob Chemother; 1989 Aug; 24(2):103-10. PubMed ID: 2676935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
    Petit A; Sirot DL; Chanal CM; Sirot JL; Labia R; Gerbaud G; Cluzel RA
    Antimicrob Agents Chemother; 1988 May; 32(5):626-30. PubMed ID: 3293523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli.
    Weber DA; Sanders CC; Bakken JS; Quinn JP
    J Infect Dis; 1990 Aug; 162(2):460-5. PubMed ID: 2197339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
    Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.
    Urban C; Mariano N; Rahman N; Queenan AM; Montenegro D; Bush K; Rahal JJ
    Microb Drug Resist; 2000; 6(4):297-303. PubMed ID: 11272258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
    Blahová J; Králiková K; Krcméry V; Schäfer V
    J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy.
    Phelps DJ; Carlton DD; Farrell CA; Kessler RE
    Antimicrob Agents Chemother; 1986 May; 29(5):845-8. PubMed ID: 3524432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    FEMS Microbiol Lett; 1989 May; 50(1-2):97-100. PubMed ID: 2661324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
    Mammeri H; Nazic H; Naas T; Poirel L; Léotard S; Nordmann P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the plasmid mediated beta-lactamase BIL-1.
    Payne DJ; Woodford N; Amyes SG
    J Antimicrob Chemother; 1992 Aug; 30(2):119-27. PubMed ID: 1399921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.
    Vatopoulos AC; Philippon A; Tzouvelekis LS; Komninou Z; Legakis NJ
    J Antimicrob Chemother; 1990 Nov; 26(5):635-48. PubMed ID: 2079446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactamase types and beta-lactam resistance of Escherichia coli strains with chromosomally mediated ampicillin resistance.
    Marre R; Aleksic S
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):44-6. PubMed ID: 2406142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.
    Bauernfeind A; Grimm H; Schweighart S
    Infection; 1990; 18(5):294-8. PubMed ID: 2276823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.